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Summary Microsatellite instability has recently been reported in sporadic and familial colorectal tumours and
can be due to defects in DNA mismatch repair genes. Such instability has subsequently been detected in several
other types of sporadic tumours. We studied 29 specimens of bone tumours with different histopathological
diagnoses and found no evidence of microsatellite instability. Our results suggest that mismatch repair defects
are unlikely to play a significant part in the tumorigenesis of bone neoplasms. Loss of heterozygosity with at
least one marker was detected in 11, i.e. in 38% of the tumour samples, most frequently with markers D2S136
at 2p (eight of 28 informative specimens, 29%) and Dl lS904 at llp (four of 21 informative specimens, 19%).
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Microsatellite instability (MI) is a recently discovered
landmark of a mutator or a replication error (RER) tumour
phenotype, which was first described in sporadic (Ionov et al.,
1993; Thibodeau et al., 1993) and hereditary (Aaltonen et al.,
1993) colorectal tumours. The identification of the RER
phenomenon gave decisive clues to the pathogenesis of
hereditary non-polyposis colorectal cancer (HNPCC). The
cancer predisposition in HNPCC has been shown to arise
from germline mutations in DNA mismatch repair genes,
most often affecting MLHI or MSH2 (Bronner et al., 1994;
Leach et al., 1993; Nicolaides et al., 1994; Papadopoulos et
al., 1994). The mismatch repair deficiency in tumours of
patients with HNPCC can be demonstrated by genotyping
tumour and normal tissue DNAs with microsatellite markers.
RER + tumours display novel microsatellite alleles not
present in the normal DNA, as a result of decreased
replication fidelity. This hypermutability is not restricted to
microsatellite sequences (Parsons et al., 1993) and is believed
to promote tumorigenesis.
Microsatellite instability has subsequently been detected in
various tumours (for reviews, see Dams et al., 1995;
Eshleman and Markowitz, 1995; Loeb, 1994), including
sporadic tumours of the endometrium, oesophagus, sto-
mach, pancreas, ovary, kidney, urinary bladder, lung, brain,
breast and prostate. MI has also been detected in skin cancer
(Quinn et al., 1995) and squamous cell carcinoma of head
and neck (Mao et al., 1994). Data about MI in
haematological malignancies are still conflicting (Robledo et
al., 1995; Silly et al., 1994; Wada et al., 1994). Whether the
molecular genetic background in the above-mentioned
RER+ tumour types is similar to HNPCC is yet unclear.
It is likely that neoplasms with few microsatellite alterations
represent still unclarified mechanisms of genetic instability
different from the one seen in HNPCC and some sporadic
colorectal tumours (Lieu et al., 1995). As MI has been
detected with a very low frequency and with only one marker
in some tumour types, it is possible that a subset of these
findings reflects only the general instability of the tumour
genome and is merely a by-product of tumour progression.
As the spectrum of tumours with microsatellite instability
has been shown to be wide, we hypothesised that such
instability might play a role in the tumorigenesis of bone
neoplasms. So far mesenchymal tumours have been screened
for RER in only one study, in which two of 18 soft-tissue
sarcomas exhibited instability with one repeat (Wooster et al.,
1994). In a study of loss of heterozygosity (LOH) in
chondrosarcomas with markers linked to multiple hereditary
exostoses loci no evidence of MI was seen (Raskind et al.,
1995). In the present study we decided to screen different
types of malignant bone tumours (e.g. osteosarcoma,
chondrosarcoma, Ewing's sarcoma, fibrosarcoma and malig-
nant fibrous histiocytoma) for the presence of RER.
Materials and methods
Twenty-nine tumour specimens representing primary bone
tumours, tumour recurrences and metastases with different
Table I The bone tumour material of the study
Sample
no. Histology *
1 Parosteal osteosarcoma R
2 Osteosarcoma gradeIII P
3 Osteosarcoma gradeIV P
4 Osteosarcoma gradeIV P
5 Osteosarcoma gradeIV P
6a Osteosarcoma gradeIV P
6b Osteosarcoma gradeIV M
7 Osteosarcoma gradeIII-IV M
8 Chondrosarcoma gradeI P
9 Chondrosarcoma gradeI P
10 Chondrosarcoma gradeI P
11 Chondrosarcoma gradeII P
12 Chondrosarcoma gradeII P
13a Chondrosarcoma gradeII P
13b Chondrosarcoma gradeII R
14a Chondrosarcoma gradeII P
14b Chondrosarcoma gradeIII R
14c Chondrosarcoma gradeIII R
15 Chondrosarcoma gradeIII P
16 Chondrosarcoma gradeIII M
17 Chondrosarcoma gradeIV P
18 Primitive neuroectodermal tumour (PNET) P
19 Ewing's sarcoma M
20a Chondromyxoid fibroma R
20b Chondromyxoid fibroma R
21 Fibrosarcoma gradeIII P
22 Malignant fibrous histiocytoma (MFH) P
gradeIV
23 Malignant fibrous histiocytoma (MFH) P
gradeIV
24 Rhabdomyosarcoma gradeIV P
*P, primary tumour; R, tumour recurrence; M, metastasis. Samples
6a and b, 13 a and b, 14a-c and 20a and b represent consecutive
samples ofthe same patients.
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Table II The microsatellite markers and the tumours in which LOH was detected
Sample D2S136 D8S255 D10S197 DIIS904 D13S175 D20S100
no. Histology (2p) (8p) (lop) (lip) (13q) (20)
3 Osteosarcoma gradeIV + + LOH LOH + +
5 Osteosarcoma gradeIV LOH + + LOH + +
6a Osteosarcoma gradeIV LOH LOH + LOH
6b Metastasis of osteosarcoma, gradeIV LOH + + +
11 Chondrosarcoma gradeII + LOH + LOH + LOH
14a Chondrosarcoma grade II LOH + + + +
14b Recurrence of chondrosarcoma, gradeIII LOH + + + +
14c Recurrence of chondrosarcoma, gradeIII LOH LOH + + + 0
15 Chondrosarcoma gradeIII + + LOH LOH +
20a Recurrence of chondromyxoid fibroma LOH + + +
20b Recurrence of chondromyxoid fibroma LOH + + +
+, Heterozygous; *, homozygous. Samples 6a and b, 14a-c and 20a and b represent consecutive samples ofthe same patients.
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Figure 1 Analysis with microsatellite marker Dl S904 (1lp)
showing all the bone tumour specimens with loss of hetero-
zygosity at this locus. N, normal blood DNA; T, tumour DNA.
Case 5, grade IV osteosarcoma; case 3, grade IV osteosarcoma;
case 11, grade II chondrosarcoma; case 15, grade III
chondrosarcoma.
histopathological diagnoses (Table I), with paired blood
DNA samples, were analysed with five to 11 randomly
chosen dinucleotide repeat markers (mean, 9.7 markers per
tumour) representing different chromosomes. The markers
were DIS216 (ip), D2S136 (2p), D5S404 (5q), D7S519 (7),
D8S255 (8p), DlOS197 (lOp), DllS904 (lip), D13S175 (13q),
D15S120 (15), D17S787 (17q) and D20S100 (20) (Gyapay et
al., 1994). PCR and electrophoresis were performed as
previously described (Peltomiiki et al., 1993). All results
were rechecked by a researcher experienced with RER
analysis (LAA).
Results
There was no evidence of microsatellite instability in the 282
paired typings of bone tumour samples, including samples of
osteosarcoma, chondrosarcoma, Ewing's sarcoma, primitive
neuroectodermal tumour (PNET), chondromyxoid fibroma,
fibrosarcoma, malignant fibrous histiocytoma and leiomyo-
sarcoma. Loss of heterozygosity was detected with at least
one marker in 11 specimens, i.e. in 38% of the tumour
samples studied (Table II, Figure 1). LOH was most
frequently detected with markers D2S136 at 2p (eight of 28
informative specimens, 29%) and Dl lS904 at lIp (four of 21
informative specimens, 19%).
Discussion
Previous allelotyping studies of bone tumours are few and
have focused on osteosarcoma (Toguchida et al., 1988;
Yamaguchi et al., 1992). These studies have found frequent
LOH in different chromosomes, most often at 13q and 17p,
probably reflecting the inactivation of RBJ and p53. The low
frequency of LOH at 13q in the present study is most
probably due to the marker D13S175 being located
proximally (13ql1) from the RBI locus (13ql4). The
detection of LOH at several different chromosome arms in
different tumour samples with varying frequency in the
present study is in agreement with previous studies. It is
possible that allelic losses detected in this study represent
random genetic alterations rather than events associated with
tumour progression.
As none of the paired typings showed microsatellite
instability, we interpret this to suggest that MI is unlikely
to be involved as a major component in the development of
bone tumours. The study by Raskind et al. (1995) reported
no MI in chondrosarcomas with markers located at 8q, the
pericentromeric region of chromosome 11, and l9p. The
results of the present study are in agreement with this study
as none of the chondrosarcomas of the present study showed
MI. Also other histopathological entities of bone tumours
were included in the present study (e.g. osteosarcoma, Table
I) and none showed MI. However, as a small proportion of
soft-tissue sarcomas exhibited a low degree of MI in a
previous study (Wooster et al., 1994), it is still possible that
microsatellite instability could be detected in a distinct
subgroup of bone tumours, at least with a low degree.
Furthermore, preliminary results of mice deficient for PMS2
or MSH2 have shown that these animals may be susceptible
to developing sarcomas (Baker et al., 1995; de Wind et al.,
1995). Further studies will clarify whether MI and defects in
mismatch repair or other mechanisms involved in the stability
of DNA might contribute to the tumorigenesis of a bone
tumour subgroup, or of mesenchymal tumours in general.
Note added in proof
The tumours have been further studied for instability of the polyA
repeat within the gene encoding TGFfl-RII (Papadopoulos et al.
(1995). Science, 268, 1915-1917), but no instability was detected.
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